Search research articles
Contact Us
Filters
Showing results (71-80 of 100) with videos related to
Page
of 10
Sort By:
Genes, Chromosomes & Cancer
|
July 1, 1990
Loss of genetic information in central nervous system tumors common to children and young adults
C D James, J He, E Carlbom, et al.
International Journal of Oncology
|
May 26, 1999
Analysis of cyclin dependent kinase inhibitors in malignant astrocytomas
C H Alleyne, J He, J Yang, et al.
Cancer Research
|
October 1, 1988
Clonal genomic alterations in glioma malignancy stages
C D James, E Carlbom, J P Dumanski, et al.
Journal of Neurosurgery
|
December 1, 1996
Transfection of IFNalpha in human glioblastoma cells and tumorigenicity in association with induction of PKR and OAS gene expression
J He, J J Olson, A J Ekstrand, et al.
Leukemia
|
July 1, 1995
Homozygous deletions of the CDKN2 (MTS1/p16ink4) gene in cell lines established from children with acute lymphoblastic leukemia
M Zhou, L Gu, C D James, et al.
Oncogene
|
April 6, 1995
Altered subcellular location of an activated and tumour-associated epidermal growth factor receptor
A J Ekstrand, L Liu, J He, et al.
Oncogene
|
August 1, 1994
Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification
A J Ekstrand, N Longo, M L Hamid, et al.
Journal of Neuropathology and Experimental Neurology
|
June 13, 2000
Amplification of the platelet-derived growth factor receptor-A (PDGFRA) gene occurs in oligodendrogliomas with grade IV anaplastic features
J S Smith, X Y Wang, J Qian, et al.
Alimentary Pharmacology & Therapeutics
|
July 6, 2004
Alosetron repeat dose pharmacokinetics, effects on enzyme activities, and influence of demographic factors
K M Koch, B W Corrigan, J Manzo, et al.
Cancer Research
|
November 15, 1994
CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines
J He, J R Allen, V P Collins, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 100) with videos related to
Sort By:
Page
of 10
Genes, Chromosomes & Cancer
|
July 1, 1990
Loss of genetic information in central nervous system tumors common to children and young adults
C D James, J He, E Carlbom, et al.
International Journal of Oncology
|
May 26, 1999
Analysis of cyclin dependent kinase inhibitors in malignant astrocytomas
C H Alleyne, J He, J Yang, et al.
Cancer Research
|
October 1, 1988
Clonal genomic alterations in glioma malignancy stages
C D James, E Carlbom, J P Dumanski, et al.
Journal of Neurosurgery
|
December 1, 1996
Transfection of IFNalpha in human glioblastoma cells and tumorigenicity in association with induction of PKR and OAS gene expression
J He, J J Olson, A J Ekstrand, et al.
Leukemia
|
July 1, 1995
Homozygous deletions of the CDKN2 (MTS1/p16ink4) gene in cell lines established from children with acute lymphoblastic leukemia
M Zhou, L Gu, C D James, et al.
Oncogene
|
April 6, 1995
Altered subcellular location of an activated and tumour-associated epidermal growth factor receptor
A J Ekstrand, L Liu, J He, et al.
Oncogene
|
August 1, 1994
Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification
A J Ekstrand, N Longo, M L Hamid, et al.
Journal of Neuropathology and Experimental Neurology
|
June 13, 2000
Amplification of the platelet-derived growth factor receptor-A (PDGFRA) gene occurs in oligodendrogliomas with grade IV anaplastic features
J S Smith, X Y Wang, J Qian, et al.
Alimentary Pharmacology & Therapeutics
|
July 6, 2004
Alosetron repeat dose pharmacokinetics, effects on enzyme activities, and influence of demographic factors
K M Koch, B W Corrigan, J Manzo, et al.
Cancer Research
|
November 15, 1994
CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines
J He, J R Allen, V P Collins, et al.
Page
of 10